DDIT3 and neoplasm: Based on our study, in response to the combined intraperitoneal injection of CHOP-siRNA along with administration of thapsigargin and the TRAIL, the inhibition of tumor growth was inferior to that of thapsigargin and TRAIL co-treatment.